Clinical significance of the DECAF score in acute exacerbations of chronic obstructive pulmonary disease
Eurasian Journal of Pulmonology · 2026
DOI: 10.14744/ejp.2026.46653 ↗Abstract
BACKGROUND AND AIM: The prognosis of chronic obstructive pulmonary disease (COPD) depends on the frequency and severity of exacerbations. The DECAF score (dyspnea, eosinopenia, consolidation, acidemia, and atrial fibrillation) is a cost-effective tool used to predict exacerbation outcomes. This study examines its relationship with six-month mortality following COPD exacerbations (ECOPD). METHODS: Patients (n=260) hospitalized at our center between December 15, 2021 and June 15, 2022 due to ECOPD were evaluated prospectively. Patients were classified into low-risk (DECAF score
EUVIMED